Skin dendritic cells progressively subvert the activation of pathogenic type-2 immunity upon epicutaneous allergen immunotherapy

Skin dendritic cells progressively subvert the activation of pathogenic type-2 immunity upon epicutaneous allergen immunotherapy

Bibliographic Details
Main Authors:	Léo Laoubi, Hugh Sampson, Lucie Mondoulet, Jean-François Nicolas, Vincent Dioszeghy, Marc Vocanson
Format:	Article
Language:	English
Published:	Elsevier 2020-08-01
Series:	World Allergy Organization Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S1939455120302404

Similar Items

Antigen Uptake by Langerhans Cells Is Required for the Induction of Regulatory T Cells and the Acquisition of Tolerance During Epicutaneous Immunotherapy in OVA-Sensitized Mice
by: Vincent Dioszeghy, et al.
Published: (2018-09-01)

Recent advances in epicutaneous immunotherapy and potential applications in food allergy
by: Pierre-Louis Hervé, et al.
Published: (2023-10-01)

Treatment of Intestinal Inflammation With Epicutaneous Immunotherapy Requires TGF-β and IL-10 but Not Foxp3+ Tregs
by: Xin Chen, et al.
Published: (2021-02-01)

Innovative delivery systems for epicutaneous immunotherapy
by: Zhen Wang, et al.
Published: (2023-08-01)

Transitioning from epicutaneous to oral peanut immunotherapy
by: Lauren Wong, et al.
Published: (2023-02-01)

The Role of Regulatory T Cells in Epicutaneous Immunotherapy for Food Allergy
by: Guirong Liu, et al.
Published: (2021-07-01)

Antigen-driven bystander effect accelerates epicutaneous sensitization with a new protein allergen
by: Yu Jhang-Sian, et al.
Published: (2009-03-01)

A Murine Model of Food Allergy by Epicutaneous Adjuvant-Free Allergen Sensitization Followed by Oral Allergen Challenge Combined with Aspirin for Enhanced Detection of Hypersensitivity Manifestations and Immunotherapy Monitoring
by: Keiko Kameda, et al.
Published: (2023-02-01)

A Perspective on the Interplay of Ultraviolet-Radiation, Skin Microbiome and Skin Resident Memory TCRαβ+ Cells
by: VijayKumar Patra, et al.
Published: (2018-05-01)

Epicutaneous sensitization with protein antigen
by: I-Lin Liu, et al.
Published: (2012-12-01)

Deciphering Differential Behavior of Immune Responses as the Foundation for Precision Dosing in Allergen Immunotherapy
by: Antoine Magnan, et al.
Published: (2023-02-01)

Modulation of dendritic cell metabolism by an MPLA-adjuvanted allergen product for specific immunotherapy
by: Jennifer Zimmermann, et al.
Published: (2022-08-01)

PDL2+ CD11b+ dermal dendritic cells capture topical antigen through hair follicles to prime LAP+ Tregs
by: Leticia Tordesillas, et al.
Published: (2018-12-01)

Establishment of an Epicutaneously Sensitized Murine Model of Shellfish Allergy and Evaluation of Skin Condition by Raman Microscopy
by: Mayuko Ichimura-Shimizu, et al.
Published: (2022-03-01)

Epicutaneous Sensitization and Food Allergy: Preventive Strategies Targeting Skin Barrier Repair—Facts and Challenges
by: Anna Dębińska, et al.
Published: (2023-02-01)

Epicutaneous sensitization. what do we know?
by: G. A. Novik, et al.
Published: (2022-01-01)

Detecting Skin Reactions in Epicutaneous Patch Testing with Deep Learning: An Evaluation of Pre-Processing and Modality Performance
by: Ioannis A. Vezakis, et al.
Published: (2023-08-01)

Allergens and allergen immunotherapy : subcutaneous, sublingual, and oral /
by: Lockey, Richard F., editor, et al.
Published: (2014)

Decorating and loading ghosts with allergens for allergen immunotherapy
by: Songwe Fanuel, et al.
Published: (2017-10-01)

Mechanisms of allergen-specific immunotherapy and allergen tolerance
by: Umut C. Kucuksezer, et al.
Published: (2020-10-01)

Nanoparticle–allergen complexes for allergen immunotherapy
by: Di Felice G, et al.
Published: (2017-06-01)

Allergen immunotherapy in China
by: Yaqi Yang, et al.
Published: (2024-01-01)

Allergen Immunotherapy in Asthma
by: Kazuyuki Nakagome, et al.
Published: (2021-10-01)

Allergen-specific immunotherapy
by: Moote William, et al.
Published: (2011-11-01)

Allergen Specific Immunotherapy
by: Esther Helen Steveling-Klein
Published: (2016-12-01)

Immunotherapy with Allergen Peptides
by: Larché Mark
Published: (2007-06-01)

Allergen Immunotherapy and Tolerance
by: Tomokazu Matsuoka, et al.
Published: (2013-01-01)

Orientia tsutsugamushi subverts dendritic cell functions by escaping from autophagy and impairing their migration.
by: Ji-Hye Choi, et al.
Published: (2013-01-01)

Protease-digested egg-white products induce oral tolerance in mice but elicit little IgE production upon epicutaneous exposure
by: Ayako Yamada, et al.
Published: (2022-10-01)

Epicutaneous Sensitization to the Phytocannabinoid β-Caryophyllene Induces Pruritic Inflammation
by: Saadet Inan, et al.
Published: (2023-09-01)

Peculiarities of epicutaneous action of hexyl ether of 5-aminolevulinic acid
by: Е.K. Vlasenko, et al.
Published: (2015-03-01)

Dual Role of Interleukin-23 in Epicutaneously-Sensitized Asthma in Mice
by: Katsunori Masaki, et al.
Published: (2014-01-01)

New modalities of allergen immunotherapy
by: Manish Ramesh, et al.
Published: (2018-12-01)

Aluminium in Allergies and Allergen immunotherapy
by: Erika Jensen-Jarolim
Published: (2015-01-01)

Characteristics of Candidates for Allergen Immunotherapy
by: Giorgio Ciprandi M.D., et al.
Published: (2013-09-01)

Future of allergen-specific immunotherapy
by: Takeru Ishikawa
Published: (1998-01-01)

New treatments for allergen immunotherapy
by: Mübeccel Akdis
Published: (2014-01-01)

Allergen immunotherapy, when and why?
by: Díez Zuluaga, Libia Susana, et al.
Published: (2015-01-01)

Allergen exposure chambers: implementation in clinical trials in allergen immunotherapy
by: O. Pfaar, et al.
Published: (2020-07-01)

Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection
by: Laurissa Ouaguia, et al.
Published: (2019-02-01)